Treatment with IL-1Ra, and thereby blocking both IL-1α and IL-1β, led to increased viral titers in the initial phase of infection (Figure 5B), whereas the absence of IL-1β alone did not affect viral replication (Figure 3B). Here, IL1A is linked to infection.